Ultragenyx Pharmaceutical (RARE) Enterprise Value Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.59% |
| Dec 31, 2025 | 3.45% |
| Sep 30, 2025 | 22.21% |
| Jun 30, 2025 | 3.98% |
| Mar 31, 2025 | 6.61% |
| Dec 31, 2024 | 6.61% |
| Sep 30, 2024 | 5.88% |
| Jun 30, 2024 | 3.34% |
| Mar 31, 2024 | 24.71% |
| Dec 31, 2023 | 21.66% |
| Sep 30, 2023 | 16.72% |
| Jun 30, 2023 | -18.04% |
| Mar 31, 2023 | 1.73% |
| Dec 31, 2022 | 0.33% |
| Sep 30, 2022 | -19.02% |
| Jun 30, 2022 | 4.25% |
| Mar 31, 2022 | 5.78% |
| Dec 31, 2021 | -17.21% |
| Sep 30, 2021 | -13.58% |
| Jun 30, 2021 | -15.62% |
| Mar 31, 2021 | -21.27% |
| Dec 31, 2020 | -72.40% |
| Sep 30, 2020 | -27.30% |
| Jun 30, 2020 | 5.65% |
| Mar 31, 2020 | -15.98% |
| Dec 31, 2019 | -25.71% |
| Sep 30, 2019 | -9.96% |
| Jun 30, 2019 | -16.42% |
| Mar 31, 2019 | -20.20% |
| Dec 31, 2018 | -1.70% |
| Sep 30, 2018 | -3.91% |
| Jun 30, 2018 | -18.84% |
| Mar 31, 2018 | -16.48% |
| Dec 31, 2017 | -7.74% |
| Sep 30, 2017 | -22.63% |
| Jun 30, 2017 | -37.64% |
| Mar 31, 2017 | -36.99% |
| Dec 31, 2016 | -442.88% |
| Sep 30, 2016 | -303.18% |
| Jun 30, 2016 | -207.26% |
| Mar 31, 2016 | -85.24% |